卡瓦克罗尔通过调节内皮原生细胞来改善高血压动物的血管功能
Tays Amanda Felisberto Gonçalves1, Viviane Silva Lima1, Arthur José Pontes Oliveira de Almeida1
1Department of Pharmaceutical Sciences, Federal University of Paraiba, João Pessoa 58059-900, PB, Brazil.
Nutrients
|July 14, 2023
概括
卡瓦克罗尔可以增强内皮原生细胞 (EPC) 功能,促进高血压的血管修复. 这种天然化合物通过促进EPC和减少氧化应激来改善血管健康.
科学领域:
- 心血管研究研究心血管研究
- 药理学 药理学是指药理学的学科.
- 细胞生物学 细胞生物学
背景情况:
- 卡瓦克罗尔是一种性单烯,表现出抗氧化和抗高血压的特性.
- 关于卡瓦克罗尔在血管再生中的作用的证据有限.
- 内皮原生细胞 (EPC) 对于修复受损血管至关重要.
研究的目的:
- 在自发高血压大鼠 (SHR) 中研究卡尔瓦克罗尔对以EPCs为媒介的内皮修复的作用.
- 在高血压模型中评估卡瓦克罗尔对EPC功能和血管健康的影响.
主要方法:
- 在SHR和Wistar京都 (WKY) 试验中,小鼠接受了四周的卡瓦克罗尔,载体或白醇治疗.
- 系统性血压 (SBP) 每周监测一次.
- EPCs被分离,量化,并评估了它们的功能 (CFU, eNOS, ROS,衰老).
- 血管组织 (上半导体动脉) 分析了ROS,CD34和CD31的表达.
主要成果:
- 卡瓦克罗尔治疗改善了EPC迁移,殖民地形成单元 (CFU) 形成和eNOS表达/活动.
- 卡瓦克罗尔减少了细胞内活性氧物种 (ROS) 和EPC中的衰老.
- 血管ROS水平下降,而CD31和CD34表达在卡瓦克罗尔治疗后增加.
结论:
- 卡尔瓦克罗尔显著增强了EPC功能,有助于改善内皮细胞修复.
- 卡瓦克罗尔在减轻内皮功能障碍和促进高血压中血管健康方面表现出潜力.
- 这些发现表明,卡瓦克罗尔是血管再生的有希望的治疗剂.
相关概念视频
01:18Hypertension and Regulation of Blood Pressure
2.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K
01:29Hypertension II: Pathophysiology
20
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
20
01:23Antihypertensive Drugs: Vasodilators
573
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
573
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
465
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
465
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
786
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
786
01:20Vascular Resistance
4.3K
Vascular resistance is a critical concept in understanding blood flow dynamics in the circulatory system. It refers to the resistance that blood encounters as it flows through the blood vessels. This resistance is a key factor in determining blood pressure and cardiac workload.
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
4.3K